Literature DB >> 8031506

Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin.

C Christiansen1, H Kryvi, P C Sontum, T Skotland.   

Abstract

Albunex is a new ultrasound contrast agent for medical imaging. The product consists of air-filled albumin microspheres suspended in a solution of 5% (w/v) human albumin. The suspension is sterile, non-pyrogenic and isotonic, with a pH of 7.0 and a viscosity of 1.4 relative to water. The contrast effect is caused by the air-filled microspheres, which range in diameter from 1 to 15 microns, with less than 5% being larger than 10 microns. The product contains a total of about 7 x 10(8) microspheres/ml of suspension. The number concentration of microspheres with diameters between 4 and 10 microns is about 2 x 10(8)/ml. The latter microsphere fraction is assumed to give the main contribution to the ultrasound signal in the left ventricle of the heart after intravenous injection. The air-filled microspheres are prepared by sonication of a heated solution of 5% (w/v) human albumin. During the sonication process, microbubbles of air are formed which become encapsulated in a thin shell of aggregated albumin about 15 nm in thickness. Due to the stabilizing effect of the albumin shell, the air-filled microsphere suspension is stable for at least 2 years when stored refrigerated. The microsphere protein represents about 1.5% of the total protein in the suspension. The remaining protein is soluble albumin molecules which behave like the albumin molecules in the starting material when analysed by a number of biochemical techniques.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031506

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  20 in total

1.  Determination of air content in protein microspheres.

Authors:  S Kvåle; K R Dyrstad; P C Sontum; O A Asbjørnsen
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

Review 2.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 5.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

6.  Material characterization of the encapsulation of an ultrasound contrast microbubble and its subharmonic response: strain-softening interfacial elasticity model.

Authors:  Shirshendu Paul; Amit Katiyar; Kausik Sarkar; Dhiman Chatterjee; William T Shi; Flemming Forsberg
Journal:  J Acoust Soc Am       Date:  2010-06       Impact factor: 1.840

Review 7.  Reverse engineering the ultrasound contrast agent.

Authors:  Mark A Borden; Kang-Ho Song
Journal:  Adv Colloid Interface Sci       Date:  2018-10-24       Impact factor: 12.984

8.  Novel preparation techniques for controlling microbubble uniformity: a comparison.

Authors:  Eleanor Stride; Mohan Edirisinghe
Journal:  Med Biol Eng Comput       Date:  2009-05-12       Impact factor: 2.602

9.  In vivo magnetic resonance vascular imaging using laser-polarized 3He microbubbles.

Authors:  M S Chawla; X J Chen; H E Möller; G P Cofer; C T Wheeler; L W Hedlund; G A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Relationship between size of injected microspheres and ultrasound imaging of heart by PLSR.

Authors:  K Dyrstad; P C Sontum
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.